SBIR/STTR awards account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of US-based small businesses as well as collaborations with Academics. SBIR/STTRs differ from traditional NIH mechanisms in that they are highly product driven and ultimately are seeking commercialization of novel therapies, diagnostics, […]
[vc_row][vc_column][vc_column_text] Ram May-Ron and Ayal Ronen of the FreeMind Group introduce the R&DMoneyView, a tool that will allow its users to gain insight into non-dilutive Federal awards made to domestic, for-profit organizations to support R&D in the Life Sciences. R&DMoneyView is the first tool in the R&DMoney suite of tools designed to streamline the granting process in […]
Representatives from federal agencies, a private foundation, and industry come together to provide insight into key industry-related initiatives from the various sources as well as the overall enthusiasm for awarding for-profit organizations. Moderator: Ayal Ronen, FreeMind Group Panelists: Dr. Michael Kurilla, NIAID Todd Merchak, NIBIB, Dr. Mark Allegretta, National MS Society Colonel Russell Coleman, DOD (JPM-MCS) Dr. […]
Colonel Russell E. Coleman of the JPM-Medical Countermeasure Systems, presents the Keynote Address: The Dilemma in the Development of Medical Countermeasures Against Chemical and Biological Weapons: An unpredictable threat and products we hope will never be used.
Dr. Michael Kurilla of the National Institute of Allergy and Infectious Diseases takes a look at the progression of Infectious Diseases, where vaccine and treatment trends may be heading, and NIAID’s role in addressing unmet needs.
Todd Merchak of the National Institute of Biomedical Imaging and Bioengineering discusses SBIR, STTR, and other grants available to support innovative R&D in medtech.
Dr. Mark Allegretta of the National MS Society shares on the Fast Forward program and their investment methods.
Evelia Johnston of The Michael J. Fox Foundation for Parkinson’s Research speaks about venture philanthropy and how the MJFF works to fulfill the unmet funding needs of R&D targeting Parkinson’s Disease.
Life Science Nation founder Dennis Ford gives insight into fundraising and tips for approaching investors.
Dr. Jak Knowles of CureDuchenne Ventures sheds light on Duchenne Muscular Dystrophy, CureDuchenne’s role in seeking a cure, and its non-dilutive and venture philanthropy funding models supporting R&D.